Menthol, Inflammation, and Nicotine Transition Study

Description

This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.

Conditions

Cigarette Smoking, Inflammatory Response

Talk to us

Study Overview

On this page

Study Details

Study overview

This study will focus on examining the potential impact of menthol flavoring in cigarettes on biomarkers of systemic inflammation as a subclinical indicator of cardiovascular disease risk.

Effect of Menthol to Non-Menthol Cigarette Switching on Subclinical Inflammatory Biomarkers of Cardiovascular Health: Simulating a Menthol Cigarette Ban

Menthol, Inflammation, and Nicotine Transition Study

Condition
Cigarette Smoking
Intervention / Treatment

-

Contacts and Locations

North Chicago

Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States, 60064

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    21 Years to 85 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    Rosalind Franklin University of Medicine and Science,

    Nancy C Jao, PhD, PRINCIPAL_INVESTIGATOR, Rosalind Franklin University of Medicine and Science

    Study Record Dates

    2026-02